Report cover image

The Market and Potential for Molecular Point of Care Diagnostics: Revenue Forecasts to 2020

Publisher Kalorama Information
Published Feb 26, 2016
Length 361 Pages
SKU # KLI5916011

Description

Molecular point-of-care (POC) diagnostics are able to improve the sensitivity and specificity of existing near-patient and rapid tests and also expand the diagnostic capabilities at points of care such as hospital critical care units, physician offices, outpatient clinics, and community health posts in the developing world.bThe Market and Potential for Molecular Point of Care Diagnostics examines the major segments of molecular POC diagnostics, exploring in-depth  current sales and market opportunity and providing the following market information:
  • Molecular POC Market for Respiratory Tract Infections (2015-2020)
  • Molecular POC Market for Women’s Health and Sexual Health (2015-2020)
  • Molecular POC Market for High-Burden Diseases (2015-2020)
  • Molecular POC Market for GI Pathogens, HAIs and Bloodstream Infections (2015-2020)
  • Molecular POC Market for Non-Infectious Diseases (2015-2020)
  • Investments in Decentralized Molecular Diagnostics Companies (2014-2015)
  • Potential Entrants into Molecular POC Diagnostics (Vendor, Current Platform[s], Primary Market for Platform, Assay Menu, Applicable Tech)

Clinical molecular diagnostics has steadily progressed from research-emergent, highly complex tests performed in few labs to analyzer-integrated and -automated steps from sample preparation through results analysis.  The Market and Potential for Molecular Point of Care Diagnostics probes molecular point of care diagnostics developments and applications, including:

  • Selected Isothermal Amplification Methods and Platform Examples
  • Selected Analyzer Platforms for Decentralized and POC Molecular Testing with Image Sensor Detectors (CCD, CMOS)
  • Selected Analyzer Platforms for Decentralized and POC Molecular Testing with Photodiode Detectors
  • Selected Analyzer Platforms for Decentralized and POC Molecular Testing with Electrochemical Detectors
  • Selected Analyzer Platforms for Decentralized and POC Molecular Testing with Immunochromatographic Detection
  • Selected NGS Platforms for Decentralized and POC Sequencing
  • Market-Available Molecular POC Diagnostic Platforms (Vendor, Assay Menu, Planned Assays, Regulatory Status, Procedure Integration, Test Principles)
  • Market-Available Hospital Molecular Diagnostic Platforms (Vendor, Assay Menu, Planned Assays, Regulatory Status, Procedure Integration, Test Principles)
  • Hospital and POC Molecular Diagnostic Platforms in Development (Vendor, Assay Menu, Procedure Integration, Test Principles)
  • Market-Available Molecular Diagnostic Platforms for Emerging Markets and the Developing World (Vendor, Assay Menu, Planned Assays, Regulatory Status, Procedure Integration, Test Principles)
  • Molecular Diagnostic Platforms in Development for Emerging Markets and the Developing World (Vendor, Assay Menu, Procedure Integration, Test Principles)
  • Line Probe Assays and Other Molecular Lateral Flow Test Strips (Vendor, Assay Menu, Planned Assays, Regulatory Status)
  • Potential Entrants into Molecular POC Diagnostics (Vendor, Current Platform[s], Primary Market for Platform, Assay Menu, Applicable Tech)
  • Selected Developmental Molecular POC-Enabling Technologies and Platforms by Vendor

Profiled companies include those with clinical molecular diagnostic systems applicable to POC testing markets; molecular diagnostic systems applicable to hospital lab molecular testing; development-stage molecular diagnostic systems for decentralized testing; molecular diagnostic products for use primarily in emerging markets of the developing world and for field testing; companies with original equipment manufacturer (OEM) platforms and component technologies that could be featured in the molecular POC diagnostics market; and other companies that have been involved in molecular POC diagnostics through investment, collaborative research or technology development that could allow them to enter the market. Companies profiled include:

  • Oxford Nanopore Technologies
  • Xagenic
  • T2 Biosystems
  • Rheonix
  • Nanosphere
  • Great Basin Scientific
  • DNA Electronics
  • Enigma Diagnostics
  • Curetis
  • Biocartis
  • Atlas Genetics

Table of Contents

361 Pages
    • INTRODUCTION
    • MOLECULAR POINT-OF-CARE DIAGNOSTICS DEFINED
    • STRENGTHS AND WEAKNESS OF MOLECULAR POC TESTING
    • COMPONENT TECHNOLOGIES OF MOLECULAR POC DIAGNOSTICS
    • LEADING PLATFORMS IN MOLECULAR POC DIAGNOSTICS
    • INVESTMENT IN DECENTRALIZED MOLECULAR DIAGNOSTICS -VENTURE FINANCING AND PUBLIC OFFERINGS (2009-2015)
    • GLOBALMOLECULAR POC DIAGNOSTICS MARKET (2015-2020)
    • MAJOR CONCLUSIONS
    • INTRODUCTION
    • POINT-OF-CARE DIAGNOSTICS IN BRIEF
    • MOLECULAR DIAGNOSTICS
    • ADVANTAGES AND DISADVANTAGES OF MOLECULAR DIAGNOSTICS AT THE POINT OF CARE
    • SUMMARY
    • INTRODUCTION
    • ADVANCES IN MOLECULAR DIAGNOSTICS
    • MOLECULAR PLATFORMS AND PRODUCTS FOR DECENTRALIZED TESTING
    • MAJOR TESTING APPLICATIONS FOR MOLECULAR POC DIAGNOSTICS
    • CONCLUSIONS
    • INTRODUCTION
    • INVESTMENT IN DECENTRALIZED MOLECULAR DIAGNOSTICS -VENTURE FINANCING AND PUBLIC OFFERINGS (2009-2015)
    • RESPIRATORY TRACT INFECTIONS
    • WOMEN'S HEALTH AND SEXUAL HEALTH
    • HIGH-BURDEN DISEASES
    • GASTROINTESTINAL, HOSPITAL-ACQUIRED AND BLOODSTREAM INFECTIONS
    • NON-INFECTIOUS DISEASE TESTS - PHARMACOGENETICS, HEREDITARY TRAITS AND CANCER
    • CONCLUSIONS
    • ABACUS DIAGNOSTICA
    • ADVANCED LIQUID LOGIC (ILLUMINA)
    • AHRAM BIOSYSTEMS
    • AKONNI BIOSYSTEMS
    • ALERE (ABBOTT)
    • AMPLINO
    • ANALYTIK JENA
    • AQUILA DIAGNOSTIC SYSTEMS
    • ATLAS GENETICS
    • AXXIN
    • BECTON, DICKINSON &CO. (BD)
    • BIOCARTIS
    • BIOMEME
    • BIOMÉRIEUX
    • CANON BIOMEDICAL
    • CEPHEID
    • CORIS BIOCONCEPT
    • COYOTE BIOSCIENCE
    • CURETIS
    • DESTINA GENOMICS
    • DIAGNOSTICS FOR ALL
    • DIAGNOSTICS FOR THE REAL WORLD
    • DIASORIN
    • DIASSESS
    • DNA ELECTRONICS
    • DXNA
    • EIKEN CHEMICAL
    • ENIGMA DIAGNOSTICS
    • ENTOPSIS
    • EPISTEM
    • ERBAMOLECULAR (LUMORA)
    • ESPIRA
    • GENAPSYS
    • GENEFLUIDICS
    • GENEPOC
    • GENEREACH BIOTECHNOLOGY
    • GNUBIO (BIO-RAD)
    • GREAT BASIN SCIENTIFIC
    • GREINER BIO-ONE
    • HAI KANG LIFE
    • HAIN LIFESCIENCE
    • HIBERGENE DIAGNSOTICS
    • ICUBATE
    • IMMUNEXPRESS
    • INSILIXA
    • LUCIGEN
    • MAST GROUP
    • MBIO DIAGNOSTICS
    • MERIDIAN BIOSCIENCE
    • MESA BIOTECH
    • METAARAMEDICAL TECHNOLOGIES
    • MICRONICS (SONY)
    • MOLBIO DIAGNOSTICS
    • MP BIOMEDICALS
    • MYCROLAB DIAGNOSTICS
    • NANOBIOSYM
    • NANOBIOSYS
    • NANODETECTION TECHNOLOGY
    • NANOIVD
    • NANOMIX
    • NANOSPHERE
    • OPTIGENE
    • ORION DIAGNOSTICA
    • OXFORD NANOPORE TECHNOLOGIES
    • POSITIVEID
    • PRETECT
    • QIAGEN
    • QUANTUMDX
    • QUIDEL
    • RHEONIX
    • ROCHE DIAGNOSTICS
    • SCANOGEN
    • SEEGENE
    • SPARTAN BIOSCIENCE
    • STAT-DIAGNOSTICA
    • T2 BIOSYSTEMS
    • THERMAL GRADIENT
    • UBIQUITOME
    • USTAR BIOTECHNOLOGIES
    • VEREDUS LABORATORIES
    • WAVE 80 BIOSCIENCES
    • XAGENIC

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us